Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action of sulphur containing tyrosine analogs

Journal of Investigative Dermatology

Volumn 113, Issue 6, 1999, Pages 928-934

  Thomas, Panakkezhum D ^a   Kishi, Hiroyuki ^b   Cao, Huamei ^b   Ota, Mayumi ^c   Yamashita, Toshiharu ^b   Singh, Shradha ^a   Jimbow, Kowichi ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotherapy; Melanogenesis; Melanoma; Phenol; Tyrosinase

Indexed keywords

SULFUR; TYROSINE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CYTOSTASIS; CYTOTOXICITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0033384965     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00781.x     Document Type: Article

References (33)

1. Alena F, Iwashina T, Gili A, Jimbow K: Selective in vivo accumulation of N-acetyl-4-S-cysteaminylphenol in B16F10 murine melanoma and enhancement of its in vitro and in vivo antimelanoma effect by combination of buthionine sulfoximine. Cancer Res 54:2661-2666, 1994
2. Ando S, Ando O, Suemoto Y, Mishima Y: Tyrosinase gene transcription and its control by melanogenic inhibitors. J Invest Dermatol 100:150S-155S, 1993
3. Balzarini J, Declercq E: Strategies for the measurement of the inhibitory effects of thymidine analogs on the activity of thymidylate synthase in intact murine leukemia L1210 cells. Biochim Biophys Acta 785:36-45, 1984
4. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
5. Chen Q, Ames BN: Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc Natl Acad Sci USA 91:4130-4134, 1994
6. Del Bino G, Skierski JS, Darzynkiewicz Z: The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195:485-491, 1991
7. Fukuyama N, Ichimori K, Su Z, Ishida H, Nakazawa H: Peroxynitrite formation from activated human leukocytes. Biochem Biophys Res Comm 224:414-419, 1996
8. Gade W, Brown JL: Purification, characterization and possible function of alpha-N-acylamino and hydrolase from bovine liver. Biochim Biophys Acta 662:86-93, 1989
9. Gili A, Jimbow K: Cytotoxicity of phenolic thioether amines in vitro. Melanoma Res in press, 1999
10. Goulian M, Bleile B, Tseng BY: Methotrexate-induced misincorporation of uracil into DNA. Proc Natl Acad Sci USA 77:1956-1960, 1980
11. Ingraham HA, Dickey L, Goulian M: DNA fragmentation and cytotoxicity from increased deoxyuridylate. Biochemistry 25:3225-3230, 1986
12. Inoue S, Hasegawa K, Ito S, et al: Antimelanoma effect of 4-S-Cysteaminylcatechol, an activated form of 4-S-Cysteaminylphenol. Cancer Res 55:2603-2607, 1995
13. 14C] phenol as a basis for development of antimelanoma and melanoma-radioimaging agent. Appl Radiat Isot 45:703-705, 1994
14. Jimbow K, Iwashina T, Alena F, Yamada K, Pankovich J, Umemura T: Exploitation of pigment biosynthesis pathway as a selective chemotherapeutic approach for malignant melanoma. J Invest Dermatol 100:231S-238S, 1993
15. Jimbow K, Hara H, Vinayagamoorthy T, et al: Molecular control of melanogenesis in malignant melanoma: Functional assessment of tyrosinase and lamp gene families by UV exposure and gene co-transfection, and cloning of a cDNA encoding calnexin, a possible melanogenesis 'Chaperone'. J Dermatol 21:894-906, 1994
16. Kitagawa M, Nemoto T, Seki S, Ito S, Kasuga T: In vivo antimelanoma effects of 4-S-cysteaminyl phenol, a newly synthesized therapeutic agent specific to melanoma. J Cancer Res Clin Oncol 119:470-474, 1993
17. Lassmann G, Potsch S: Structure of transient radicals from cytostatic-active p-alkoxyphenols by continuous-flow EPR. Free Rad Biol Med 19:533-539, 1995
18. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin reagents. J Biol Chem 193:265-275, 1951
19. Minamitsuji Y, Toyofuku K, Sugiyama S, Yamada K, Jimbow K: Sulphur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-meduted apoptosis. J Invest Dermatol 4:130-136, 1999
20. Miura S, Ueda T, Jimbow K, Ito S, Fujita K: Synthesis of cysteinylphenol, cysteaminylphenol and related compounds and in vivo evaluation of antimelanoma effect. Arch Dermatol Res 279:219-225, 1987
21. Miura T, Jimbow K, Ito S: The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its N-acetyl derivative. Int J Cancer 46:931-934, 1990
22. Offen D, Ziv T, Gorodin S, Barzilai A, Malik Z, Melamed E: Dopamine-induced programmed cell death in mouse thymocytes. Biochim Biophys Acta 1268:171-177, 1995
23. Pantazis P, Early JA, Metidoza JT, Dejesus AR, Giovanella BC: Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro. Cancer 54:771-776, 1994
24. Parsons PG, Favier D, McEwan M, Takahashi H, Jimbow K, Ito S: Action of cysteaminylphenols on human melanoma cells in vivo and in vitro: 4-S-cysteaminylphenol binds protein disulphide isomerase. Melanoma Res 1:97-104, 1992
25. Prezioso JA, Wang N, Bloomer WO: Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminyl phenol and N-acetyl-4-S-cysteaminyl phenol. Cancer Chemother Pharmacol 30:394-400, 1992
26. Riley PA: Melanogenesis: a realistic target for antimelanoma therapy? Eur J Cancer 27:1172-1177, 1991
27. Schmitz S, Allen TM, Jimbow K: Polyethylene-glycol-mediated delivery of liposome-entrapped pigments into fibroblasts: experimental pigment cells as models for mutator phenotypes. Cancer Res 52:6638-6645, 1992
28. Sjodin K, Nilsson E, Hallberg A, Tunek A: Metabolism of N-acetyl-L-cysteine. Biochem Pharmacol 38:3981-3985, 1989
29. Tandon M, Thomas PD, Shokravi M, Singh S, Samra S, Chang D, Jimbow K: Synthesis of the melanogenesis-based antimelanoma agent, N-Propionyl-4-cysteaminylphenol, and screening of depigmenting and anti-tumour effects. Bio Pharmacol 55:2023-2029, 1998
30. Vindelov LL, Christensen IJ, Nissen NI: A detergent-trypsin method for the preparation of melei for flow cytometric DNA analysis. Cytometry 3:323-327, 1983
31. Wong M, Jimbow K: Selective cytotoxidty of N-acetyl-4-S-cysteaminylphenol on follicular melanocytes of black mice. Br J Dermatol 124:56-61, 1991
32. Yamada K, Jimbow K: Selective in vivo and in vitro incorporation and accumulation of phenolic thioether amine into malignant melanoma and identification of a (58 kDa) binding glycoprotein. Melanoma Res 2:225-233, 1992
33. Yamada K, Jimbow K, Engelhardt R, Ito S: Selective cytotoxicity of a phenolic melanin precursor, 4-S-cysteaminylphenol, on in vitro melanoma cells. Biochem Pharmacol 38:2217-2221, 1989